National Health Investors (NHI) Stock Price, News & Analysis

Company Overview

National Health Investors, Inc. (NYSE:NHI) is a real estate investment trust that owns and finances income-producing healthcare real estate in the United States. The company primarily focuses on properties serving older adults and patients who require specialized care.

NHI’s portfolio includes independent living communities, assisted living and memory care facilities, skilled nursing facilities, continuing care retirement communities, medical office buildings and other healthcare-related properties. The company generally leases properties to healthcare operators under long-term agreements, allowing those operators to manage and provide resident and patient services while NHI focuses on real estate ownership and investment.

Founded in 1991, National Health Investors has built a nationwide portfolio serving the senior housing and post-acute care markets. The company is headquartered in Murfreesboro, Tennessee, and is led by President and Chief Executive Officer Eric Mendelsohn.

Key Stats

• Today's Range: $66.90 to $67.80
• 50-Day Range: $64.03 to $73.59
• 52-Week Range: $63.51 to $91.38
• Volume: 269,393 shs
• Average Volume: 283,747 shs
• Market Capitalization: $3.29 billion
• P/E Ratio: 19.37
• Dividend Yield: 5.61%
• Price Target: $81.00
• Consensus Rating: Moderate Buy

National Health Investors Stock Analysis - MarketRank™

National Health Investors scored higher than 79% of companies evaluated by MarketBeat, and ranked 53rd out of 189 stocks in the real estate sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.9 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

National Health Investors has received a consensus rating of Moderate Buy. The company's average rating score is 2.56, and is based on no strong buy ratings, 5 buy ratings, 4 hold ratings, and no sell ratings.

Upside Potential

National Health Investors has a consensus price target of $81.00, representing about 20.9% upside from its current price of $67.02.

Amount of Analyst Coverage

National Health Investors has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 4.62%

Earnings Growth

Earnings for National Health Investors are expected to grow by 4.62% in the coming year, from $4.76 to $4.98 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of National Health Investors is 19.37, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 26.95.

Price to Earnings Ratio vs. Sector

The P/E ratio of National Health Investors is 19.37, which means that it is trading at a less expensive P/E ratio than the Real Estate sector average P/E ratio of about 27.96.

Price to Earnings Growth Ratio

National Health Investors has a PEG Ratio of 4.27. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

National Health Investors has a P/B Ratio of 2.09. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

4.67% of the float of National Health Investors has been sold short.

Short Interest Ratio / Days to Cover

National Health Investors has a short interest ratio ("days to cover") of 6.59.

Change versus previous month

Short interest in National Health Investors has recently decreased by 6.75%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Leadership

National Health Investors is a leading dividend payer. It pays a dividend yield of 5.61%, putting its dividend yield in the top 25% of dividend-paying stocks.

Dividend Growth

National Health Investors does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of National Health Investors is 108.67%. Payout ratios above 75% are not desirable because they may not be sustainable.

Dividend Sustainability

Based on EPS estimates, National Health Investors will have a dividend payout ratio of 75.50% in the coming year. This indicates that National Health Investors may not be able to sustain their current dividend.

News and Social Media

• Score: 0.6 / 5
• News Sentiment: N/A

News Coverage This Week

MarketBeat has tracked 1 news article for National Health Investors this week, compared to 2 articles on an average week.

Search Interest

Only 8 people have searched for NHI on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

MarketBeat Follows

2 people have added National Health Investors to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 0.8 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, National Health Investors insiders have not sold or bought any company stock.

Percentage Held by Insiders

2.70% of the stock of National Health Investors is held by insiders.

Percentage Held by Institutions

62.51% of the stock of National Health Investors is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Record date for 8/7 Dividend: 6/30/2026
• Ex-Dividend for 8/7 Dividend: 6/30/2026
• Dividend Payable: 8/07/2026
• Last Earnings: 8/10/2026
• Record date for 11/6 Dividend: 9/30/2026
• Ex-Dividend for 11/6 Dividend: 9/30/2026
• Today: 11/01/2026
• Dividend Payable: 11/06/2026
• Next Earnings (Estimated): 11/09/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Real Estate
• Industry: Healthcare REITs
• Sub-Industry: Healthcare REITs
• Current Symbol: NYSE:NHI
• CIK: 877860
• Web: www.nhireit.com
• Phone: (615) 890-9100
• Fax: 615-225-3030
• Employees: 32
• Year Founded: 1991

Price Target and Rating

• Average Price Target for National Health Investors: $81.00
• High Price Target: $94.00
• Low Price Target: $68.00
• Potential Upside/Downside: +20.9%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.56
• Research Coverage: 9 Analysts

Profitability

• EPS (Trailing Twelve Months): $3.46
• Trailing P/E Ratio: 19.37
• Forward P/E Ratio: 14.08
• P/E Growth: 4.27
• Net Income: $142.18 million
• Net Margins: 38.56%
• Pretax Margin: 38.80%
• Return on Equity: 10.89%
• Return on Assets: 5.88%

Debt

• Debt-to-Equity Ratio: 0.81
• Current Ratio: 6.78
• Quick Ratio: 6.78

Sales & Book Value

• Annual Sales: $375.63 million
• Price / Sales: 8.76
• Cash Flow: $4.79 per share
• Price / Cash Flow: 13.99
• Book Value: $32.11 per share
• Price / Book: 2.09

Miscellaneous

• Outstanding Shares: 49,110,000
• Free Float: 47,784,000
• Market Cap: $3.29 billion
• Optionable: Optionable
• Beta: 0.49